A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure

NCT00260923 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
641
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis